EyePoint Pharmaceuticals
EYPT
#6805
Rank
โ‚น41.15 B
Marketcap
โ‚น602.98
Share price
-0.28%
Change (1 day)
-65.11%
Change (1 year)

Revenue for EyePoint Pharmaceuticals (EYPT)

Revenue in 2024 (TTM): โ‚น3.81 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚น3.88 Billion. In 2023 the company made a revenue of โ‚น3.83 Billion an increase over the revenue in the year 2022 that were of โ‚น3.42 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for EyePoint Pharmaceuticals from 2003 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น3.81 B-0.46%
2023 โ‚น3.83 B11.81%
2022 โ‚น3.42 B24.62%
2021 โ‚น2.74 B9.17%
2020 โ‚น2.51 B73.43%
2019 โ‚น1.45 B
2017 โ‚น0.16 B-64.35%
2016 โ‚น0.46 B306.66%
2015 โ‚น0.11 B-93.55%
2014 โ‚น1.78 B1214.46%
2013 โ‚น0.13 B4.23%
2012 โ‚น0.13 B-61.37%
2011 โ‚น0.33 B-56.13%
2010 โ‚น0.76 B25.28%
2009 โ‚น0.61 B41.28%
2008 โ‚น0.43 B1371.16%
2007 โ‚น29.47 M-67.7%
2006 โ‚น91.24 M49.68%
2005 โ‚น60.95 M225.77%
2004 โ‚น18.71 M131.43%
2003 โ‚น8.08 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น12.24 B 215.35%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A Bahamas